July 1, 2025

Digestive Disorders

Expert Says New Study Offers Hope for Improved Recovery and Lower Risk of Recurrent Colorectal Cancer for Patients Through Physical Activity | Newswise

Expert Says New Study Offers Hope for Improved Recovery and Lower Risk of Recurrent Colorectal Cancer for Patients Through Physical Activity | Newswise

David Bale04 mins

Newswise — A West Virginia University expert said the findings of a new study that followed colorectal cancer patients and their treatment outcomes, which included guided exercise and physical activity, are particularly meaningful for West Virginians. Stephenie Kennedy-Rea, a cancer researcher in the WVU School of Medicine Department of Cancer Prevention and Control, explained that…

Read More
Tracking Microbial Rhythms Reveals New Target for Treating Metabolic Diseases | Newswise

Tracking Microbial Rhythms Reveals New Target for Treating Metabolic Diseases | Newswise

David Bale011 mins

Newswise — The gut microbiome, a vast assortment of bacteria and other microorganisms that inhabit our digestive system, plays a critical role in converting food into energy. Many of these microbes follow rhythmic cycles of activity throughout the day. However, high-fat diets and other factors can disrupt these rhythms and contribute to metabolic disease. A…

Read More
Tip Sheet: A New Treatment for Metastatic Colorectal Cancer, Discoveries for Small Cell Lung Cancer — and a State-of-the-Art Learning Lab for Community Education | Newswise

Tip Sheet: A New Treatment for Metastatic Colorectal Cancer, Discoveries for Small Cell Lung Cancer — and a State-of-the-Art Learning Lab for Community Education | Newswise

David Bale010 mins

Newswise — SEATTLE — June 4, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. Check out a video of Fred Hutch Advanced Practice Providers (APPs) giving recommendations for reducing skin cancer risk on Instagram, Facebook and TikTok. Cancer research and treatment New hope for people…

Read More
7 Questions About Hernias | Newswise

7 Questions About Hernias | Newswise

David Bale09 mins

Newswise — You may know what a hernia is, but do you know that a hernia without pain may be a ticking time bomb in your gut? To emphasize the importance of getting your hernia examined as soon as possible, we asked Maurizio Miglietta, D.O., a board-certified general surgeon at Hackensack Meridian Pascack Valley Medical Center,…

Read More
From Basic Research to Clinic: Both Diagnostic and Therapeutic Use of the Microbiota Will Become Reality Within the Next 5-10 Years | Newswise

From Basic Research to Clinic: Both Diagnostic and Therapeutic Use of the Microbiota Will Become Reality Within the Next 5-10 Years | Newswise

David Bale09 mins

Newswise — This prospect emerges from an article published in Cell by experts from Gemelli and the Catholic University The article summarizes results of research and possible future clinical applications of the microbiome and provides instructions for doctors. More communication is needed between basic and clinical research to accelerate the arrival of this valuable tool…

Read More
Imunoterapia potencializa quimioterapia no combate ao câncer colorretal em estágio 3 | Newswise

Imunoterapia potencializa quimioterapia no combate ao câncer colorretal em estágio 3 | Newswise

David Bale08 mins

Newswise — ROCHESTER, Minnesota — O câncer colorretal é o terceiro tipo mais comum no mundo. Embora o exame preventivo tenha ajudado a detectar e prevenir a disseminação do câncer colorretal, os principais avanços em seu tratamento parecem lentos. Agora, uma nova pesquisa realizada pelo Mayo Clinic Comprehensive Cancer Center (Centro de Câncer da Mayo…

Read More
Diet Influences Survival After Stage III Colon Cancer, Dana-Farber Study Finds | Newswise

Diet Influences Survival After Stage III Colon Cancer, Dana-Farber Study Finds | Newswise

David Bale09 mins

Newswise — BOSTON, June 1, 2025 – Patients with colon cancer who consumed an anti-inflammatory diet during a phase 3 clinical trial showed longer overall survival post-treatment compared to those on a proinflammatory diet, according to a Dana-Farber Cancer Institute analysis. Engaging in higher levels of physical activity may amplify the positive influence on survival….

Read More
Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimen Improves Outcomes in Stage 3 Colon Cancer, Study Finds | Newswise

Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimen Improves Outcomes in Stage 3 Colon Cancer, Study Finds | Newswise

David Bale08 mins

Newswise — BOSTON, June 1, 2025 – Combining standard adjuvant chemotherapy with an immune checkpoint inhibitor (atezolizumab) leads to a significant improvement in disease-free survival in a subset of patients with stage 3 colon cancer that is deficient in DNA mismatch repair (dMMR), Dana-Farber Cancer Institute investigator Dr. Jeffrey Meyerhardt and his colleagues report at…

Read More